Anzeige
Mehr »
Mittwoch, 06.08.2025 - Börsentäglich über 12.000 News
US-Kupfer-Geheimtipp legt nach: Strategisches Projekt zündet Phase 2 mit KI-Bohrplanung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1W1KK | ISIN: US23282W6057 | Ticker-Symbol: KK3A
Tradegate
06.08.25 | 16:47
30,000 Euro
-4,46 % -1,400
1-Jahres-Chart
CYTOKINETICS INC Chart 1 Jahr
5-Tage-Chart
CYTOKINETICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
29,80030,00020:08
29,60029,80019:44

Aktuelle News zur CYTOKINETICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.07.Raymond James downgrades Cytokinetics stock rating to Market Perform5
29.07.Raymond James stuft Cytokinetics auf "Market Perform" herab2
24.07.Cytokinetics, Incorporated: Cytokinetics to Announce Second Quarter Results On August 7, 20251
18.07.Cytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)111SOUTH SAN FRANCISCO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on July 16, 2025 it granted stock options to purchase an aggregate of...
► Artikel lesen
10.07.Cytokinetics, Incorporated: Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 202511
06.07.Piper Sandler Maintains a Buy Rating on Cytokinetics (CYTK) With a $107 PT6
17.06.Cytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)181SOUTH SAN FRANCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on June 15, 2025 it granted stock options to purchase an aggregate of...
► Artikel lesen
12.06.Cytokinetics, Incorporated (CYTK) Price Target Lowered To $53 from $71 at JPMorgan4
CYTOKINETICS Aktie jetzt für 0€ handeln
10.06.Cytokinetics Calls for Donations4
10.06.Cytokinetics, Incorporated: Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program2
04.06.Cytokinetics auf der Jefferies-Konferenz: Marktexpansion für Aficamten22
29.05.Mizuho senkt Kursziel für Cytokinetics-Aktie von 103 auf 84 US-Dollar6
29.05.Mizuho cuts Cytokinetics stock target to $84 from $1031
27.05.Stifel maintains Buy rating and $87 target on Cytokinetics stock1
18.05.Cytokinetics, Incorporated: Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress5
16.05.Cytokinetics, Incorporated: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)190SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on May 15, 2025 it granted stock options to purchase an aggregate of 40...
► Artikel lesen
15.05.Cytokinetics shares positive phase 3 results for aficamten in heart disease9
15.05.Cytokinetics, Incorporated: Cytokinetics to Host Symposium on Contemporary Landscapes in Muscle Biology1
13.05.Stifel maintains confidence in Cytokinetics stock post-trial success1
13.05.Cytokinetics rises as lead drug succeeds in late-stage trial5
Weiter >>
99 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1